AUA Guidelines: Treatment Of Non - Metastatic Muscle - Invasive Bladder Cancer
Guest: Jeffrey M Holzbeierlein, MD
Outline:
Segment #1: Guideline Statement 9-Patients who have not received cisplatin-based NAC and have pT3-4 and/or N= disease at cystectomy should receive adjuvant cisplatin based chemotherapy or adjuvant immunotherapy.
Segment #2: Guideline ... Show More
Nov 19
Core Curriculum: Surgical Management of Urolithiasis
Core Curriculum: Surgical Management of Urolithiasis
AUA Urology Core Curriculum: auau.auanet.org/core
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guests: Marcelino E. Rivera, MD and T. Max Shelton, MD
Outline:
Segment 1: Acute Stone Event and Radiographic Evaluation
Segment 2: Shock ... Show More
36m 39s
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
56m 23s
Dec 2022
Dr. Lazaros Tzelves discusses underactive bladder (UAB) in women
<p>In this edition, Dr. Lazaros Tzelves (GR), a member of the EAU Guidelines Panel for non-neurogenic female LUTS, discusses underactive bladder (UAB) in women. <br/><br/>Dr. Tzelves clinically defines what an underactive bladder is, followed by sharing information on its prevale ... Show More
8m 39s
Oct 2022
Dr Thomas Seisen talks about treatment options for metastatic UTUC
<p>During this episode, Dr. Thomas Seisen (FR), an associate member on the EAU Guidelines Panel for Non-Muscle Invasive Bladder Cancer, answers questions about metastatic upper urothelial cancer (UTUC) treatment options in the 2022 guidelines:</p><ul><li>What are the systemic tr ... Show More
17m 11s